CCC
PFE icon

Chelsea Counsel Company’s Pfizer PFE Stock Holding History

Chelsea Counsel Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562K Buy
+20,000
New +$532K 0.25% 60
2025
Q1 		– Sell
-23,295
Closed -$618K – 206
2024
Q4 		$618K Sell
23,295
-2,575
-10% -$69.8K 0.32% 55
2024
Q3 		$749K Sell
25,870
-300
-1% -$8.75K 0.37% 55
2024
Q2 		$732K Sell
26,170
-1,630
-6% -$44.9K 0.37% 54
2024
Q1 		$771K Sell
27,800
-80
-0.3% -$2.22K 0.44% 42
2023
Q4 		$803K Sell
27,880
-4,195
-13% -$127K 0.43% 48
2023
Q3 		$1.06M Sell
32,075
-5,300
-14% -$187K 0.55% 41
2023
Q2 		$1.37M Sell
37,375
-5,200
-12% -$202K 0.67% 37
2023
Q1 		$1.74M Sell
42,575
-1,300
-3% -$56.1K 0.84% 32
2022
Q4 		$2.25M Sell
43,875
-3,560
-8% -$171K 1.12% 26
2022
Q3 		$2.08M Sell
47,435
-15,367
-24% -$747K 1.28% 25
2022
Q2 		$3.29M Sell
62,802
-9,787
-13% -$499K 1.69% 16
2022
Q1 		$3.76M Sell
72,589
-25,807
-26% -$1.34M 1.66% 18
2021
Q4 		$5.81M Sell
98,396
-11,480
-10% -$569K 2.52% 11
2021
Q3 		$4.72M Buy
109,876
+2,275
+2% +$101K 2.15% 15
2021
Q2 		$4.21M Buy
107,601
+2,220
+2% +$86.3K 1.94% 16
2021
Q1 		$3.82M Buy
105,381
+475
+0.5% +$16.9K 1.89% 17
2020
Q4 		$3.86M Buy
104,906
+50,665
+93% +$1.86M 1.99% 17
2020
Q3 		$1.89M Buy
54,241
+23
+0% +$806 1.12% 26
2020
Q2 		$1.68M Buy
54,218
+9,087
+20% +$309K 1.04% 31
2020
Q1 		$1.4M Sell
45,131
-527
-1% -$18K 1.1% 29
2019
Q4 		$1.7M Sell
45,658
-106
-0.2% -$3.78K 1.03% 31
2019
Q3 		$1.56M Sell
45,764
-527
-1% -$19.2K 0.94% 32
2019
Q2 		$1.9M Sell
46,291
-20
-0% -$794 1.02% 27
2019
Q1 		$1.87M Sell
46,311
-158
-0.3% -$6.33K 1.01% 30
2018
Q4 		$1.92M Hold
46,469
– – 1.17% 26
2018
Q3 		$1.94M Hold
46,469
– – 1.01% 30
2018
Q2 		$1.6M Buy
46,469
+40,522
+681% +$1.38M 0.95% 32
2018
Q1 		$200K Hold
5,947
– – 0.13% 67
2017
Q4 		$204K Sell
5,947
-2,635
-31% -$89.8K 0.11% 81
2017
Q3 		$291K Hold
8,582
– – 0.15% 74
2017
Q2 		$273K Sell
8,582
-2,569
-23% -$81K 0.14% 72
2017
Q1 		$362K Buy
11,151
+10
+0.1% +$315 0.19% 70
2016
Q4 		$343K Buy
11,141
+122
+1% +$3.73K 0.18% 72
2016
Q3 		$354K Hold
11,019
– – 0.18% 72
2016
Q2 		$368K Sell
11,019
-88,902
-89% -$2.84M 0.17% 76
2016
Q1 		$2.81M Hold
99,921
– – 0.9% 39
2015
Q4 		$3.06M Buy
99,921
+23,244
+30% +$731K 0.92% 36
2015
Q3 		$2.29M Buy
76,677
+63,240
+471% +$2.03M 0.54% 45
2015
Q2 		$427K Hold
13,437
– – 0.1% 104
2015
Q1 		$444K Buy
13,437
+2,160
+19% +$68.7K 0.1% 92
2014
Q4 		$333K Sell
11,277
-175
-2% -$5.02K 0.07% 106
2014
Q3 		$321K Buy
11,452
+2,070
+22% +$58.1K 0.06% 104
2014
Q2 		$264K Sell
9,382
-1,038
-10% -$29.6K 0.05% 107
2014
Q1 		$318K Hold
10,420
– – 0.06% 99
2013
Q4 		$303K Sell
10,420
-830
-7% -$24.2K 0.07% 84
2013
Q3 		$307K Buy
11,250
+105
+0.9% +$2.86K 0.06% 92
2013
Q2 		$296K Buy
+11,145
New +$308K 0.08% 80

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Chelsea Counsel Company's PFE Position: Q1 2026 in Review

Chelsea Counsel Company opened a new position in Pfizer (PFE) in Q1 2026: 20,000 shares worth $562K. The stake represents 0.25% of the portfolio and ranks #60 among its holdings. This is a return to the name: Chelsea Counsel Company previously reported a position in PFE as recently as Q4 2024.

Chelsea Counsel Company first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.81M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Chelsea Counsel Company held 20,000 shares of Pfizer worth $562K as of Q1 2026.
  • Pfizer was a new Chelsea Counsel Company position in Q1 2026.
  • Pfizer made up 0.25% of Chelsea Counsel Company's portfolio in Q1 2026, its #60 holding.
  • Chelsea Counsel Company first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
  • Chelsea Counsel Company's Pfizer position peaked at $5.81M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.